BioAtla, Inc.

BCAB Nasdaq SEC CIK 1826892
Follow BioAtla Weekly email: filings, results, news

Financials

Reported figures only · latest: Q2 2026 USD · US GAAP
Net income $452K +102.4% vs same quarter last year
EPS, diluted $0.27 +101.7% vs same quarter last year
Operating cash flow −$419K +97% vs same quarter last year
Operating income $227K +101.2% vs same quarter last year
Net income by quarter
−$10.6M
$124.7M
−$15.3M
−$18.7M
−$15.8M
$109.4M
−$6.3M
$452K
Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income8 fiscal years
−$200M−$100M$0$100M$200MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearNet income
FY25$59.6M
FY24$69.8M
FY23$123.5M
FY22−$106.5M
FY21−$95.4M
FY20−$35.9M
FY19−$29.9M
FY18-

News

No stories filed under BioAtla yet - coverage appears here as the news feed clusters it.